迈得医疗工业设备股份有限公司关于股份回购进展公告

Group 1 - The company has approved a share repurchase plan using funds from its initial public offering or its own funds, with a total repurchase amount between RMB 20 million and RMB 40 million, and a maximum repurchase price of RMB 24 per share [1] - As of January 2026, the company has repurchased a total of 1,297,052 shares, representing 0.7803% of the total share capital of 166,219,690 shares, with a total expenditure of RMB 20,660,204.79 [2][3] - The repurchase activities are in compliance with relevant laws and regulations, and the company will continue to make repurchase decisions based on market conditions within the specified timeframe [4]